SwedenBIO - branschorganisationen för life science

CombiGene AB

Developing new treatments for neurological disorders with better precision, increased efficacy and fewer side effects.

By combining modern neuroscience with recent advances in gene delivery, CombiGene has developed a method shown to suppress epileptic seizures in preclinical studies. Our current focus is on continuing to develop this method into an effective and safe therapy for epilepsy patients, but the method may also have development potential as a means of treating other neurological disorders.

Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen, CombiGene has offices at Medicon Village in Lund, Sweden.


Kategorier: Biotech, Pharma

Gå till CombiGene ABs hemsida